CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Curis, Inc.
Curis, Inc.
AVM Biotechnology Inc
AbbVie
Cancer Research UK
Cancer Research UK
Cancer Research UK
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center